Effects of intrathecal and intravenous administration of dexmedetomidine on motor function recovery and inflammatory response in rats with spinal cord injury (Record no. 15794)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | a |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20211228145619.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 211228b xxu||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | AIKTC-KRRC |
| Transcribing agency | AIKTC-KRRC |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 15161 |
| Author | Chai, Y. |
| 245 ## - TITLE STATEMENT | |
| Title | Effects of intrathecal and intravenous administration of dexmedetomidine on motor function recovery and inflammatory response in rats with spinal cord injury |
| 250 ## - EDITION STATEMENT | |
| Volume, Issue number | Vol.83(2), March-April |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Mumbai |
| Name of publisher, distributor, etc. | Indian Journal of Pharmaceutical Science |
| Year | 2021 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Pagination | 380-386p. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | To analyze the e ffects of intrathecal and intravenous dexmedetomidine on motor function recovery and in flammatory response in rats with spinal cord injury. The rats were divided into three groups, the right femoral sheath injection group (3 μg/kg), the right femoral sheath injection group (3 μg/kg) Dexmedetomidine ( μg/kg), Inhibitor kappa B kinase inhibitor group (intrathecal injection of 50 μl/kg BMS-345541). Neuromotor function, pathological changes of spinal cord tissue, apoptosis rate of spinal cord tissue and changes of in flammatory factors were observed. The neuromotor function scores of rats in intrathecal group, intravenous group and intrathecal+intravenous group were significantly higher than those in model group at 24 h and 48 h after treatment (p<0.05) and those in intrathecal+intravenous group were significantly higher than those in intrathecal group at 24 h and 48 h after treatment, with statistical significance (p<0.05). In intrathecal group, vein group and intrathecal+vein group, the injury of nerve tissue structure was mild, the cells were slightly swollen and the cytoplasm was uniform. The apoptosis number of spinal cord injury tissue in intrathecal group, intravenous group and intrathecal+venous group was significantly lower than that of model group (p<0.05), and the apoptosis number of intrathecal+venous group was signi ficantly lower than that of intrathecal group (p<0.05). The expression of interleukin-1 β, interleukin-6 and tumor necrosis factor- α messenger RNA in intrathecal group, intravenous group and intrathecal+venous group was signi ficantly lower than that in model group (p<0.05), while the mRNA expression of interleukin-1 β, interleukin-6 and tumor necrosis factor- α in intrathecal+venous group was significantly lower than that in intrathecal group (p<0.05). The expressions of inhibitor kappa B kinase β, nuclear factor kappa-light-chain-enhancer of activated B cells messenger RNA and protein in the Inhibitor kappa B kinase β inhibitor group and dexmedetomidine group were signi ficantly lower than those in the model group (p<0.05) and the expressions of inhibitor kappa B kinaseβ, nuclear factor kappa-light-chain- enhancer of activated B cells messenger RNA and protein in the dexmedetomidine group were significantly lower than those in the inhibitor kappa B kinase β inhibitor group (p<0.05). Intrathecal and intravenous dexmedetomidine can significantly improve the recovery of neuromotor function and reduce inflammatory response in rats with spinal cord injury. The mechanism may be related to the inhibition of inhibitor kappa B kinase/ nuclear factor kappa-light-chain-enhancer of activated B cells signaling pathway. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| 9 (RLIN) | 4639 |
| Topical term or geographic name entry element | PHARMACEUTICS |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 15163 |
| Co-Author | Wei, Shuxin |
| 773 0# - HOST ITEM ENTRY | |
| Title | Indian journal of pharmaceutical sciences |
| Place, publisher, and date of publication | New Delhi |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| URL | https://www.ijpsonline.com/articles/effects-of-intrathecal-and-intravenous-administrationof-dexmedetomidine-on-motor-function-recovery-andinflammatory-respo.pdf |
| Link text | Click here |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | |
| Koha item type | Articles Abstract Database |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Permanent Location | Current Location | Shelving location | Date acquired | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| School of Pharmacy | School of Pharmacy | Archieval Section | 2021-12-28 | 2021-2022614 | 2021-12-28 | 2021-12-28 | Articles Abstract Database |